Publications by authors named "Ana Maria Fuentes Coronel"
Background: Ulcerative proctitis (UP) can have a milder, less aggressive course than left-sided colitis or extensive colitis. Therefore, immunosuppressants tend to be used less in patients with this condition. Evidence, however, is scarce because these patients are excluded from randomised controlled clinical trials.
View Article and Find Full Text PDFCorrection: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. 2021, , 2885.
J Clin Med
September 2022
The authors wish to make the following corrections to this paper [...
View Article and Find Full Text PDFPreferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study.
Therap Adv Gastroenterol
November 2021
Article Synopsis
- * Results indicated high levels of satisfaction with the 80 mg EOW regimen, reflected in a total TSQM score of 83.4, and most patients (74%) preferred the new regimen for its effectiveness and convenience, with minimal interference in daily activities.
- * Health-related quality of life scores were also high, with participants reporting an average EQ-5D score of 72.3 and SIBDQ-9 score of 75.1, suggesting the new dosing regimen positively impacted the
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year.
View Article and Find Full Text PDF